CA2779532C - Synergistic antiviral composition and use thereof - Google Patents
Synergistic antiviral composition and use thereof Download PDFInfo
- Publication number
- CA2779532C CA2779532C CA2779532A CA2779532A CA2779532C CA 2779532 C CA2779532 C CA 2779532C CA 2779532 A CA2779532 A CA 2779532A CA 2779532 A CA2779532 A CA 2779532A CA 2779532 C CA2779532 C CA 2779532C
- Authority
- CA
- Canada
- Prior art keywords
- iota
- carrageenan
- kappa
- neuraminidase inhibitor
- infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/731—Carrageenans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28214809P | 2009-12-22 | 2009-12-22 | |
| US61/282,148 | 2009-12-22 | ||
| PCT/EP2010/007726 WO2011076367A2 (en) | 2009-12-22 | 2010-12-17 | Synergistic antiviral composition and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2779532A1 CA2779532A1 (en) | 2011-06-30 |
| CA2779532C true CA2779532C (en) | 2018-05-22 |
Family
ID=44063696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2779532A Active CA2779532C (en) | 2009-12-22 | 2010-12-17 | Synergistic antiviral composition and use thereof |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10022449B2 (https=) |
| EP (1) | EP2515889B1 (https=) |
| JP (1) | JP5902628B2 (https=) |
| KR (1) | KR101862415B1 (https=) |
| CN (1) | CN102652017A (https=) |
| AU (1) | AU2010335594B2 (https=) |
| BR (1) | BR112012015202B1 (https=) |
| CA (1) | CA2779532C (https=) |
| CL (1) | CL2012001695A1 (https=) |
| DK (1) | DK2515889T3 (https=) |
| EA (1) | EA022840B1 (https=) |
| ES (1) | ES2531367T3 (https=) |
| IL (1) | IL219552A (https=) |
| MX (1) | MX2012007166A (https=) |
| NZ (1) | NZ599839A (https=) |
| PL (1) | PL2515889T3 (https=) |
| PT (1) | PT2515889E (https=) |
| SG (1) | SG181421A1 (https=) |
| SI (1) | SI2515889T1 (https=) |
| WO (1) | WO2011076367A2 (https=) |
| ZA (1) | ZA201202482B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012126777A1 (en) * | 2011-03-18 | 2012-09-27 | Marinomed Biotechnologie Gmbh | Inhibition of neuraminidase activity |
| RU2469020C1 (ru) * | 2011-11-08 | 2012-12-10 | Александр Васильевич Иващенко | (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения |
| RU2520836C1 (ru) * | 2013-02-27 | 2014-06-27 | Александр Васильевич Иващенко | (3r,4r,5s)-4-амино-5-(2,2-дифторацетиламино)-3-(1-этилпропокси)-циклогекс-1-енкарбоновая кислота и ее эфиры, способ их получения и применения |
| RS58731B1 (sr) * | 2014-01-22 | 2019-06-28 | Visufarma B V | Kompozicija koja sadrži jota-karagenan protiv virusnog konjuktivitisa |
| US12594285B2 (en) | 2016-02-25 | 2026-04-07 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
| EP3419629A4 (en) * | 2016-02-25 | 2019-10-30 | Applied Biological Laboratories, Inc. | COMPOSITIONS AND PROCEDURES FOR PROTECTION AGAINST AIRBORNE PATHOGENES AND IRRITATES |
| WO2019069307A1 (en) * | 2017-10-06 | 2019-04-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | PEPTIDES FOR THE TREATMENT OF VIRAL INFECTIONS |
| WO2019160261A1 (ko) * | 2018-02-14 | 2019-08-22 | (주)나노메디카 | 항바이러스 처리 방법, 항바이러스 필터, 및 이를 구비한 마스크 |
| KR102316819B1 (ko) * | 2018-04-20 | 2021-10-25 | 한미약품 주식회사 | 카라기난을 유효성분으로 포함하는 보존성이 개선된 액상 제제 |
| GB2579600B (en) | 2018-12-05 | 2023-07-05 | Byotrol Plc | Anti-viral composition |
| US12245754B2 (en) * | 2019-07-03 | 2025-03-11 | Aillis Inc. | Pharmaceutical composition for treating influenza virus infections |
| CN116209435A (zh) * | 2020-03-18 | 2023-06-02 | 因斯特科技公司 | 用于治疗冠状病毒感染和呼吸功能损伤的组合物和方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6593314B1 (en) * | 1999-10-19 | 2003-07-15 | Abbott Laboratories | Neuraminidase inhibitors |
| JP2001181188A (ja) * | 1999-12-28 | 2001-07-03 | Marine Biotechnol Inst Co Ltd | インフルエンザウイルス感染阻害剤 |
| KR101437708B1 (ko) | 2006-12-05 | 2014-09-03 | 마리노메드 바이오테크놀로지 게엠베하 | 항바이러스 조성물과 이의 이용 방법 |
| EP1930015A1 (en) * | 2006-12-05 | 2008-06-11 | Marinomed Biotechnologie GmbH | Use of carrageenan for treating rhinovirus infections |
| WO2008147468A2 (en) * | 2006-12-18 | 2008-12-04 | Amcol International | Compositions comprising virus-interacting layered phyllosilicates and a therapeutic agent, and methods of use |
| HRP20130402T1 (hr) * | 2007-08-24 | 2013-06-30 | Marinomed Biotechnologie Gmbh | Antivirusni pripravak koji sadrži sulfatirani polisaharid: jota-karagenan |
-
2010
- 2010-12-17 US US13/513,961 patent/US10022449B2/en active Active
- 2010-12-17 MX MX2012007166A patent/MX2012007166A/es active IP Right Grant
- 2010-12-17 EA EA201290373A patent/EA022840B1/ru unknown
- 2010-12-17 CN CN2010800551771A patent/CN102652017A/zh active Pending
- 2010-12-17 JP JP2012545143A patent/JP5902628B2/ja active Active
- 2010-12-17 WO PCT/EP2010/007726 patent/WO2011076367A2/en not_active Ceased
- 2010-12-17 ES ES10810910T patent/ES2531367T3/es active Active
- 2010-12-17 EP EP10810910.9A patent/EP2515889B1/en active Active
- 2010-12-17 NZ NZ599839A patent/NZ599839A/en unknown
- 2010-12-17 SG SG2012033643A patent/SG181421A1/en unknown
- 2010-12-17 SI SI201030883T patent/SI2515889T1/sl unknown
- 2010-12-17 CA CA2779532A patent/CA2779532C/en active Active
- 2010-12-17 DK DK10810910.9T patent/DK2515889T3/en active
- 2010-12-17 PT PT10810910T patent/PT2515889E/pt unknown
- 2010-12-17 AU AU2010335594A patent/AU2010335594B2/en active Active
- 2010-12-17 KR KR1020127016072A patent/KR101862415B1/ko active Active
- 2010-12-17 PL PL10810910T patent/PL2515889T3/pl unknown
- 2010-12-17 BR BR112012015202-5A patent/BR112012015202B1/pt active IP Right Grant
-
2012
- 2012-05-03 IL IL219552A patent/IL219552A/en active IP Right Grant
- 2012-05-04 ZA ZA2012/02482A patent/ZA201202482B/en unknown
- 2012-06-21 CL CL2012001695A patent/CL2012001695A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012015202B1 (pt) | 2020-12-08 |
| KR101862415B1 (ko) | 2018-05-29 |
| SG181421A1 (en) | 2012-07-30 |
| PL2515889T3 (pl) | 2015-05-29 |
| EA022840B1 (ru) | 2016-03-31 |
| CN102652017A (zh) | 2012-08-29 |
| US10022449B2 (en) | 2018-07-17 |
| JP5902628B2 (ja) | 2016-04-13 |
| CA2779532A1 (en) | 2011-06-30 |
| US20120302522A1 (en) | 2012-11-29 |
| EA201290373A1 (ru) | 2012-11-30 |
| BR112012015202A2 (pt) | 2016-04-05 |
| WO2011076367A2 (en) | 2011-06-30 |
| EP2515889A2 (en) | 2012-10-31 |
| IL219552A0 (en) | 2012-06-28 |
| NZ599839A (en) | 2014-02-28 |
| AU2010335594A1 (en) | 2012-05-24 |
| KR20120107970A (ko) | 2012-10-04 |
| AU2010335594B2 (en) | 2015-05-21 |
| SI2515889T1 (sl) | 2015-04-30 |
| EP2515889B1 (en) | 2014-12-10 |
| WO2011076367A3 (en) | 2011-09-01 |
| IL219552A (en) | 2016-11-30 |
| MX2012007166A (es) | 2012-07-23 |
| ZA201202482B (en) | 2012-12-27 |
| JP2013515022A (ja) | 2013-05-02 |
| CL2012001695A1 (es) | 2013-03-08 |
| DK2515889T3 (en) | 2015-03-02 |
| ES2531367T3 (es) | 2015-03-13 |
| PT2515889E (pt) | 2015-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2779532C (en) | Synergistic antiviral composition and use thereof | |
| FI2265257T4 (fi) | Aklidiniumia käsittävä inhalaatiokoostumus kroonisen keuhkoahtaumataudin hoitamiseksi | |
| US20220387455A1 (en) | Treatment of moderate to severe influenza | |
| MX2014002125A (es) | Tratamiento de sintomas asociados a gastroparesia femenina. | |
| JP2022019937A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物 | |
| JP5828007B2 (ja) | 局所投与型の嚥下障害改善用医薬品 | |
| AU2021235223A1 (en) | Composition for the treatment of lesions of the respiratory system | |
| HK1174835A (en) | Synergistic antiviral composition and use thereof | |
| EP3906934B1 (en) | Application of dalargin for the prevention of viral respiratory infections and prevention of the development of complications during viral respiratory infections | |
| US20240415944A1 (en) | Aqueous aprotinin-containing antiviral pharmaceutical composition | |
| WO2025067689A1 (en) | 5-amino-2,3-dihydro-1,4-phthalazinedione for the treatment of infections with an rna virus | |
| KR102088662B1 (ko) | 연하장애 개선용 의약품 | |
| JP2021161105A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20151120 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 14TH ANNIV.) - STANDARD Year of fee payment: 14 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241128 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20241128 Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241128 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260128 |